Thibaut Duparc

Thibaut Duparc

Auto-generated profile, based on publicly available information

Thibaut Duparc

Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2016 in Nature Medicine
Verified
Journal Article
Open access
HPHubert Plovier
Hubert Plovier
AEAmandine Everard
Amandine Everard
CDCéline Druart
Céline Druart
CDClara Depommier
Clara Depommier
MHMatthias Van Hul
Matthias Van Hul
Patrice CaniPatrice Cani
Patrice Cani
Akkermansia muciniphila, a member of the gut microbiome, has been shown to improve metabolism in mice. Here it is reported that its pasteurization further improves this effect, and that one of its membrane proteins by itself has a similar benefit.

14 December 2016 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
CPCamilla Pedersen
Camilla Pedersen
EGEdith Gallagher
Edith Gallagher
FHFelicity Horton
Felicity Horton
RERichard J. Ellis
Richard J. Ellis
UIUmer Zeeshan Ijaz
Umer Zeeshan Ijaz
MRM. Denise Robertson
M. Denise Robertson
Aberrant microbiota composition and function have been linked to several pathologies, including type 2 diabetes. In animal models, prebiotics induce favourable changes in the intestinal microbiota, intestinal permeability (IP) and endotoxaemia, which are linked to concurrent improvement in glucose tolerance. This is the first study to investigate the link between IP, glucose tolerance and intestinal bacteria in human type 2 diabetes. In all, twenty-nine men with well-controlled type 2 diabetes were randomised to a prebiotic (galacto-oligosaccharide mixture) or placebo (maltodextrin) supplement (5·5 g/d for 12 weeks). Intestinal microbial community structure, IP, endotoxaemia, inflammatory markers and glucose tolerance were assessed at baseline and post intervention. IP was estimated by the urinary recovery of oral51Cr-EDTA and glucose tolerance by insulin-modified intravenous glucose tolerance test. Intestinal microbial community analysis was performed by high-throughput next-generation sequencing of 16S rRNA amplicons and quantitative PCR. Prebiotic fibre supplementation had no significant effects on clinical outcomes or bacterial abundances compared with placebo; however, changes in the bacterial family Veillonellaceae correlated inversely with changes in glucose response and IL-6 levels (r−0·90,P=0·042 for both) following prebiotic intake. The absence of significant changes to the microbial community structure at a prebiotic dosage/length of supplementation shown to be effective in healthy individuals is an important finding. We propose that concurrent metformin treatment and the high heterogeneity of human type 2 diabetes may have played a significant role. The current study does not provide evidence for the role of prebiotics in the treatment of type 2 diabetes.

18 May 2020 in Scientific Reports
Verified
Journal Article
Open access
TDThibaut Duparc
Thibaut Duparc
JRJean-Bernard Ruidavets
Jean-Bernard Ruidavets
AGAnnelise Genoux
Annelise Genoux
CICécile Ingueneau
Cécile Ingueneau
SNSouad Najib
Souad Najib
LMLaurent O. Martínez
Laurent O. Martínez
HDL-Cholesterol (HDL-C) is not an accurate surrogate marker to measure the cardioprotective functions of HDL in coronary artery diseases (CAD) patients. Hence, measurement of other HDL-related parameters may have prognostic superiority over HDL-C. In this work, we examined the predictive value of HDL particles profile for long-term mortality in CAD patients and to compare its informative value to that of HDL-C and apoA-I. HDL particles profiles were measured by nuclear magnetic resonance (NMR) spectroscopy in 214 male participants with stable CAD (45–74 years). Median follow up was 12.5 years with a 36.4% mortality rate. Cardiovascular mortality accounted for 64.5%. Mean concentrations of total HDL particles (HDL-P), small-sized HDL (SHDL-P) and apoA-I were lower in deceased than in surviving patients whereas no difference was observed according to HDL-C and large HDL particles. All NMR-HDL measures were correlated between themselves and with other HDL markers (HDL-C, apoA-I and LpA-I). In a multivariate model adjusted for cardiovascular risk factors and bioclinical variables, HDL-P and SHDL-P displayed the strongest inverse association with all-cause and cardiovascular mortality. Weaker associations were recorded for apoA-I. Based on our results, we conclude that HDL particle profile measured by NMR spectroscopy should be considered to better stratify risk in population at high risk or in the setting of pharmacotherapy.

2 April 2018 in Physiological Reports
Verified
Journal Article
Open access
PDF file
CPCamilla Pedersen
Camilla Pedersen
UIUmer Zeeshan Ijaz
Umer Zeeshan Ijaz
EGEdith Gallagher
Edith Gallagher
FHFelicity Horton
Felicity Horton
RERichard J. Ellis
Richard J. Ellis
MRM. Denise Robertson
M. Denise Robertson
Type 2 diabetes (T2D) has been linked with increased intestinal permeability, but the clinical significance of this phenomenon remains unknown. The objective of this study was to investigate the potential link between glucose control, intestinal permeability, diet and intestinal microbiota in patients with T2D. Thirty‐two males with well‐controlled T2D and 30 age‐matched male controls without diabetes were enrolled in a case–control study. Metabolic parameters, inflammatory markers, endotoxemia, and intestinal microbiota in individuals subdivided into high (HP) and normal (LP) colonic permeability groups, were the main outcomes. In T2D, the HP group had significantly higher fasting glucose (P = 0.034) and plasma nonesterified fatty acid levels (P = 0.049) compared with the LP group. Increased colonic permeability was also linked with altered abundances of selected microbial taxa. The microbiota of both T2D and control HP groups was enriched with Enterobacteriales. In conclusion, high intestinal permeability was associated with poorer fasting glucose control in T2D patients and changes in some microbial taxa in both T2D patients and nondiabetic controls. Therefore, enrichment in the gram‐negative order Enterobacteriales may characterize impaired colonic permeability prior to/independently from a disruption in glucose tolerance.

1 April 2019 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
MJManuel Johanns
Manuel Johanns
SKSamanta Kviklyte
Samanta Kviklyte
SCSheng-Ju Chuang
Sheng-Ju Chuang
KCKatrien Corbeels
Katrien Corbeels
RJRoxane Jacobs
Roxane Jacobs
MRMark Rider
Mark Rider

1 September 2017 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
GCG. Cardouat
G. Cardouat
TDT. Duparc
T. Duparc
SFS. Fried
S. Fried
BPB. Perret
B. Perret
SNSouad Najib
Souad Najib
LMLaurent O. Martínez
Laurent O. Martínez